Novartis India share price jumped over 17 percent on Friday morning after Swiss parent Novaris AG announced the exit from the ...

ChrysCapital is set to acquire a majority stake in Novartis India from Novartis AG, marking its first major pharma investment ...

The deal, expected to close by Q3 2026, includes a mandatory open offer for public shareholders at ₹860.64 per share.

Novartis AG will sell its entire 70.68% stake in Novartis India to a ChrysCapital-led consortium for Rs 1,446 crore, ...

If the deal goes through, it would mark the first majority deal for Chrys Capital in the Indian pharma segment, sources told ...

Novartis India's shares surged 20% following Novartis AG's decision to sell a 70.68% stake to ChrysCapital. This move triggers an open offer for public shareholders to tender up to 26% of shares. The ...

Investing.com-- Shares of Novartis’ (SIX:NOVN) Indian unit surged about 20% on Friday after the Swiss drugmaker agreed to exit the business in a deal valued at 14.46 billion rupees ($159 million), ...

Novartis India will change its name to remove all references to the Novartis group within 120 days of completion.

Novartis AG has a 70.68% stake in its Indian arm. A consortium of WaveRise Investments, ChrysCapital Fund X and Two Infinity ...

The acquirers have announced an open offer to purchase up to 64,19,608 shares, representing 26% of the voting share capital, ...

Swiss drug firm Novartis said it will sell its entire stake of nearly 71% in its listed Indian subsidiary for about Rs 1,446 ...

As part of the transaction, three acquirers, namely WaveRise Investments Limited, ChrysCapital Fund X and Two Infinity Partners, will collectively purchase the promoter stake.